David Wojciechowski, DO
University of Texas Southwestern Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
3
all conditions, ClinicalTrials.gov
NIH grants tied to them
21
121 more share only the name and are not shown
Trial papers
0
PubMed author-name match
Trials
Studies that name David Wojciechowski, DO as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:14 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06958796 · Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)Camille N. Kotton, MD · recruiting · Cytomegalovirus, Organ Transplant, Kidney Transplant; Complications · principal investigator
- N/ANCT06336863 · Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only ImmunosuppressionUniversity of Texas Southwestern Medical Center · enrolling by invitation · Kidney Transplant Immunosuppression · principal investigator
- Ph4NCT04786067 · Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only ImmunosuppressionUniversity of Texas Southwestern Medical Center · completed · Kidney Transplant Immunosuppression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 121 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Artificial Intelligence for Thoracic Aortic Disease Screening and Gene DiscoveryK08HL173697 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2025 to 2026 · $164,151 awarded in 2026Same name and institution; not confirmed by an ID
- Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never beforeOT2OD032720 · OD · UNIVERSITY OF SOUTH FLORIDA · fiscal years 2022 to 2025 · $4,215,002 awarded in 2025Same name and institution; not confirmed by an ID
- Translational Control of Conidial Germination in Aspergillus fumigatusR21AI186304 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2024 to 2025 · $232,500 awarded in 2025Same name and institution; not confirmed by an ID
- Coordinate Regulation of an Alcohol Protective Response by the Liver-derived Hormone FGF21R01AA028473 · NIAAA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2020 to 2024 · $369,000 awarded in 2024Same name and institution; not confirmed by an ID
- Translational Control of Host Environmental Stress Responses in Candida albicansR01AI178973 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2024 · $247,348 awarded in 2024Same name and institution; not confirmed by an ID
- Translational Regulation of Candida glabrata Azole ResistanceR21AI172207 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2023 to 2024 · $232,500 awarded in 2024Same name and institution; not confirmed by an ID
- Regulation of Candida albicans gene expression in response to host environmental stressesR56AI167359 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2023 · $582,026 awarded in 2023Same name and institution; not confirmed by an ID
- Regulation of Multidrug Resistance in the Emerging Human Fungal Pathogen Candida aurisR21AI164719 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2021 to 2022 · $232,500 awarded in 2022Same name and institution; not confirmed by an ID
- Translational Control of Morphology and Virulence in Candida albicansR01AI127692 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2018 to 2022 · $377,985 awarded in 2022Same name and institution; not confirmed by an ID
- Mechanisms of Drug Action and DispositionT32GM007062 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2013 to 2020 · $329,596 awarded in 2020Same name and institution; not confirmed by an ID
- Regulation of Protein Synthesis During the C. albicans-Macrophage InteractionR21AI142560 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2019 to 2020 · $193,840 awarded in 2020Same name and institution; not confirmed by an ID
- Project-002UL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2017 to 2019 · $1,385,821 awarded in 2019Same name and institution; not confirmed by an ID
- Translational Control of Antifungal Resistance in Candida albicansR21AI130668 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2017 to 2018 · $228,750 awarded in 2018Same name and institution; not confirmed by an ID
- Translational Control of Biofilm Development and Maintenance in Oral CandidiasisR21AI129883 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2017 to 2018 · $202,499 awarded in 2018Same name and institution; not confirmed by an ID
- Core-002P50GM060338 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2013 to 2017 · $191,017 awarded in 2017Same name and institution; not confirmed by an ID
- Mechanisms of fenofibrate alone or combined with propranolol in burned patientsR01GM056687 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2014 to 2017 · $1,082,036 awarded in 2017Same name and institution; not confirmed by an ID
- Postdoctoral Training in Trauma and BurnsT32GM008256 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2013 to 2017 · $220,796 awarded in 2017Same name and institution; not confirmed by an ID
- Development of Safety Management and Leadership Training for Logging ContractorsU01OH010815 · NIOSH · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · fiscal years 2014 to 2016 · $274,934 awarded in 2016Same name and institution; not confirmed by an ID
- Evolution of the Morphology-Virulence Relationship in Candida SpeciesR21AI117299 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2015 to 2016 · $189,380 awarded in 2016Same name and institution; not confirmed by an ID
- Determination of morphology and virulence in Candida albicansR01AI083344 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2013 to 2014 · $383,775 awarded in 2014Same name and institution; not confirmed by an ID
- Mechanical Signaling Mechanisms in Cardiac TissueR01HL068838 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · fiscal years 2013 · $297,902 awarded in 2013Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.